Delivery of Nanoparticles for the Treatment of Cardiovascular Diseases
Global Journal of Obesity, Diabetes and Metabolic Syndrome · 09.12.2015 · 018-021
DOI: 10.17352/2455-8583.000010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Journal of Obesity, Diabetes and Metabolic Syndrome, online erschienen am 09.12.2015. Verfasst von CT Sengel. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Cardiovascular diseases are still one of the major causes of death for the people in the world. Biomedical implantable devices are the basic approach on the treatment of cardiovascular diseases. However, unexpected and serious complications can be observed in the case of their usage. Nanotechnology gives a promising perspective to overcome these drawbacks. Nanoparticulate drug delivery systems have develop superior medical solutions and offer better prospects to patients. This review comprehensively summarizes the recent situation, the benefits and the role of nanocarriers in cardiovascular implant technology.
Zitieren
APA
Sengel, C. (2015). Delivery of Nanoparticles for the Treatment of Cardiovascular Diseases. Global Journal of Obesity, Diabetes and Metabolic Syndrome, 018-021. https://doi.org/10.17352/2455-8583.000010
Vancouver
Sengel C. Delivery of Nanoparticles for the Treatment of Cardiovascular Diseases. Global Journal of Obesity, Diabetes and Metabolic Syndrome. 2015:018-021. doi:10.17352/2455-8583.000010
BibTeX
@article{Sengel2015,
author = {Sengel, CT},
title = {Delivery of Nanoparticles for the Treatment of Cardiovascular Diseases},
journal = {Global Journal of Obesity, Diabetes and Metabolic Syndrome},
year = {2015},
pages = {018--021},
doi = {10.17352/2455-8583.000010}
}
EUVIMED